Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Citi
Johnson and Johnson
Teva
Dow
Argus Health
McKesson
US Army

Generated: September 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,987,094

« Back to Dashboard

Which drugs does patent 6,987,094 protect, and when does it expire?

Patent 6,987,094 protects BETHKIS and is included in one NDA.

This patent has thirty-six patent family members in twenty-six countries.

Summary for Patent: 6,987,094
Title:Optimized formulation of tobramycin for aerosolization
Abstract: The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium Pseudomonas aeruginosa associated to lung diseases such as cystic fibrosis.
Inventor(s): Malvolti; Chiara (Parma, IT), Garzia; Raffaella (Parma, IT)
Assignee: Chiesi Farmaceutici S.p.A. (Parma, IT)
Application Number:10/482,224
Patent Claim Types:
see list of patent claims
Formulation; Process;

Drugs Protected by US Patent 6,987,094

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chiesi Usa Inc BETHKIS tobramycin SOLUTION;INHALATION 201820-001 Oct 12, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,987,094

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
01116071Jul 02, 2001
PCT Information
PCT FiledJune 14, 2002PCT Application Number:PCT/EP02/06544
PCT Publication Date:January 16, 2003PCT Publication Number: WO03/004005

International Family Members for US Patent 6,987,094

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 267591 ➤ Try a Free Trial
Australia 2002319226 ➤ Try a Free Trial
Bulgaria 108475 ➤ Try a Free Trial
Bulgaria 66328 ➤ Try a Free Trial
Brazil 0211320 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Cipla
Fish and Richardson
QuintilesIMS
Argus Health
Merck
Moodys
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.